We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

7 Mar 2022 18:32

RNS Number : 9333D
Maven Income and Growth VCT 3 PLC
07 March 2022
 

Maven Income and Growth VCT 3 PLC

 

Final results for the year ended 30 November 2021

 

The Directors report the Company's financial results for the year ended 30 November 2021.

 

Highlights

 

• NAV total return at the year end of 152.97p per share (2020: 144.44p)

 

• NAV at the year end of 62.55p per share (2020: 56.27p), after total dividend payments of 2.25p per share during the year

 

• Interim dividend of 1.25p per share paid on 10 September 2021

 

• Second interim dividend of 2.00p per share to be paid on 11 March 2022

 

• Final dividend of 1.50p per share has been proposed for payment on 26 April 2022

 

• Offer for Subscription launched and seeking to raise up to £20 million

 

Chairman's Statement

 

On behalf of your Board, I am pleased to announce the results for the financial year to 30 November 2021. This has been a year of good progress, despite the ongoing challenges in the wider economy resulting from the pandemic. Your Company is reporting an increase in NAV total return to 152.97p per share and a higher level of tax-free Shareholder distributions. Your Company has now achieved 13 consecutive years of growth in NAV total return, which demonstrates the strength and resilience of the underlying portfolio. During the year, a number of private companies have made further commercial progress, which has resulted in uplifts to certain valuations, whilst the AIM quoted portfolio has also performed well. Three profitable realisations from the private company portfolio were completed during the year and GENinCode floated on AIM generating a 2.7x uplift in value at the time of the IPO. Shortly after the period end, the holding in Quorum Cyber was realised for an overall money multiple of 6.5x inclusive of a retained minority holding.

 

Overview

 

The first half of the financial year was dominated by ongoing disruption in relation to COVID-19, as a second wave of infection hit the UK, resulting in the re-introduction of protective measures and a further nationwide lockdown. The success of the vaccination roll-out and the gradual easing of restrictions from late spring onwards resulted in a significant improvement in economic activity. However, the subsequent emergence of the Omicron variant caused further market uncertainty towards the end of the financial year.

 

It is encouraging to report that your Company has continued to make good progress in line with its core strategic objective, which is focused on building a large and broadly based portfolio of private and AIM quoted companies that are capable of achieving scale and generating a capital gain on exit. In order to facilitate the continued development and expansion of the portfolio, in late September 2021, your Company launched joint Offers for Subscription alongside Maven Income and Growth VCT 4 PLC, to raise £10 million each, with an over-allotment facility of up to a further £10 million for each company. Following good levels of early interest, it is encouraging to report that at the timing of writing £10.42 million has been raised by your Company and the Directors would like to remind Shareholders, and any potential investors, that the Offer remains open until 4 April 2022 for the 2021/22 tax year and 27 May 2022 for the 2022/23 tax year, unless it is fully subscribed ahead of this date. Further details about the Offer can be found at www.mavencp.com/vctoffer.

 

It has now been over six years since the VCT rules changed and redefined the criteria of VCT qualifying investments. During this period, significant progress has been made in constructing a diverse portfolio of high growth private company holdings across a wide range of sectors. The Board is pleased to report that many of the earlier stage portfolio companies are now achieving scale and delivering their strategic and commercial growth objectives. In certain cases, this has required a flexing or pivot of the business model to adapt to a fundamental shift in market dynamics, or to meet a new opportunity. Across the portfolio there are examples of investee companies that have delivered good commercial progress, often measured in terms of growth in contracted recurring revenue, and it is pleasing to note that, this has resulted in uplifts to several valuations. Your Company also benefits from a portfolio of later stage investments, completed prior to the change in VCT rules, and these more mature holdings remain a core component of the portfolio helping to counterbalance the higher risk associated with investment in earlier stage high growth companies.

 

The AIM quoted portfolio now accounts for 9% of net assets and has delivered a positive performance, recording a total gain of £1.33 million during the year. The Directors believe that selective investment in AIM offers exposure to a wider range of growth companies often with more favourable liquidity characteristics and it is anticipated that further new investments will be made in the year ahead. A notable highlight of the financial year was the successful flotation on AIM of investee company GENinCode, which completed in July 2021 and generated an uplift in value of 2.7x cost at the time of IPO, over a holding period of approximately one year. The objective to achieve a market listing was quickly identified as a key target for GENinCode that would help accelerate the future growth and development of the business. The Directors are pleased to note the active role played by Maven's AIM team in completing this transaction.

 

During the year, there has been a resurgence in exit activity across the portfolio, which resulted in the profitable realisations of the holdings in Curo Compensation, eSafe and Mojo Mortgages, generating returns on cost of 1.1x, 1.4x and up to 1.8x respectively. Post the period end, your Company achieved its most significant return to date from the early stage portfolio with the realisation of the holding in Quorum Cyber, which achieved an overall money multiple return of 6.5x inclusive of a retained minority holding in the business. This successful realisation helps to demonstrate the ability of certain early stage companies to generate meaningful growth in Shareholder value over a relatively short period of time. Although the timing of exits is often hard to predict, based on the progress achieved, the Directors are optimistic that further profitable exits can be achieved in the year ahead to help to underpin future dividend payments.

 

Shareholders will find full details of the portfolio developments together with a summary of the new investments completed and realisations achieved in the Investment Manager's Review in the Annual Report.

 

COVID-19

 

Whilst the success of the UK's vaccination programme has enabled the economy and our society to resume most day-to-day activities, the pandemic continues to be a dominant feature and the emergence of the Omicron variant in late 2021 was a timely reminder that the virus has the potential to cause further disruption during the year ahead.

 

Historically, your Company has maintained a relatively low level of direct exposure to consumer facing sectors such as retail, leisure, travel, hospitality and entertainment, which were most severely impacted by the pandemic. The Manager's focus on investing in dynamic businesses with strong, often counter-cyclical, growth characteristics has proven to be a sound strategy, that has helped to insulate the portfolio from the worst impact of the pandemic. It is also encouraging that several investee companies, specifically those that are active in the biotech or medtech space, have contributed towards the UK's effort to tackle COVID-19, including developing testing and therapeutics, or manufacturing medical products and devices.

 

Throughout the period, the Manager has adhered to all Government and local guidelines, with its regional offices and administration hub moving to a remote working model in March 2020. During this period, full operational capability has been maintained and there has been no impact on the management or running of your Company. The Maven offices have now fully re-opened and it is anticipated that 2022 will see a return to a normalised office based working pattern.

 

Until recently all Board Meetings were conducted via Microsoft Teams, which has proven to be an effective medium. However, face to face Meetings have now resumed and, subject to any further changes in Government guidance, will continue to follow the traditional in person format. It is also intended that the 2022 AGM will also take place in person, full details of which can be found in the Notice of Annual General Meeting in the Annual Report.

 

Brexit

 

The UK formally left the EU on 31 January 2020 and entered into an eleven month transition period that ended on 31 December 2020, with the EU (Future Relationship) Act 2020 coming into effect on 1 January 2021.

 

The Manager had been working closely with portfolio companies both prior to and during the transition period, in order to help identify any potential issues and to put in place contingency measures to mitigate against perceived problems such as supply chain disruption or staffing shortages. It is encouraging to report that, whilst the majority of the investee companies have limited direct exposure to the EU, there have been no significant indirect issues of note beyond the general market uncertainty that have affected the wider UK economy.

 

There is now greater clarity on the impact of Brexit and, whilst it is likely that there will be issues that impact across the economy, the Directors are comfortable that the sectoral diversity of the portfolio, as well as its UK focus, should ensure that your Company is well positioned to benefit from economic growth in the years to come.

 

Registration Services

 

Following a review of the registration and receiving agency services provided by a number of suppliers, and after undertaking extensive due diligence on its service features and operations, The City Partnership (UK) Limited (City Partnership) was appointed as the Registrar to your Company and the other Maven managed VCTs with effect from 25 October 2021, and is also acting as Receiving Agent for the current Offers.

 

Shareholders should have received a welcome letter from the new Registrar, including an invitation to register for its online portal at maven-cp.cityhub.uk.com/login. A separate enclosure from City Partnership, detailing the benefits of using the online portal and how to register, is included with this Annual Report.

 

The Board and the Manager are encouraged by the performance and service provided by City Partnership to date, both in terms of the management of the share register and activities related to the current Offers.

 

Dividend Policy

 

Decisions on distributions take into consideration a number of factors, including the realisation of capital gains, the adequacy of distributable reserves, the availability of surplus revenue and the VCT qualifying level, all of which are kept under close and regular review.

 

The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the considerations outlined above, will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the preceding year end. It should be noted that the effect of paying a dividend is to reduce the NAV of the Company by the total cost of the distribution.

 

The Directors would like to remind Shareholders that, as the portfolio continues to expand and a greater proportion of holdings are invested in early stage companies, the timing of distributions will be more closely linked to realisation activity, whilst also reflecting the Company's requirement to maintain its VCT qualifying level. If larger distributions are required as a consequence of significant exits, this will result in a corresponding reduction in NAV per share. However, your Board considers this to be a tax efficient means of returning value to Shareholders, whilst ensuring ongoing compliance with the requirements of the VCT legislation.

 

Further Interim Dividend and Proposed Final Dividend

 

In light of the recent realisation activity, your Board was pleased to declare a second interim dividend of 2.00p per Ordinary Share in respect of the year ended 30 November 2021, which will be paid on 11 March 2022 to Shareholders on the register at 11 February 2022.

 

Furthermore, your Board is pleased to propose that a final dividend of 1.50p per Ordinary Share, in respect of the year ended 30 November 2021, will be paid on 26 April 2022 to Shareholders on the register at 25 March 2022. This will bring total distributions for the financial year to 4.75p per Ordinary Share, representing a yield of 8.44% based on the NAV at the preceding year end of 56.27p per share. Since the Company's launch, and after receipt of the proposed final dividend, Shareholders will have received 93.92p per share in tax-free distributions.

 

Dividend Investment Scheme (DIS)

 

The Directors would like to remind Shareholders that your Company operates a DIS, through which dividend payments can be utilised to subscribe for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax relief applicable to the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances.

 

Shareholders can elect to participate in the DIS in respect of future dividends, including the payment of the proposed final dividend, to be paid on 26 April 2022, by completing a DIS mandate, which must be received by the Registrar (City Partnership) before 8 April 2022, this being the relevant dividend election date. The mandate form, terms & conditions and full details of the scheme (including further details about tax considerations) are available from the Company's website at www.mavencp.com/migvct3. Election to participate in the DIS can also be made through the Registrar's share portal at maven-cp.cityhub.uk.com/login.

 

If a Shareholder is in any doubt about the merits of participating in the DIS, or their own tax status, they should seek advice from a suitably qualified adviser.

 

Fund Raising and Allotment

 

On 20 September 2021, your Company, together with the board of Maven Income and Growth VCT 4 PLC, launched joint Offers for Subscription for new Ordinary Shares of up to £20 million in aggregate (£10 million for each company), with a combined over-allotment facility of up to £20 million (£10 million for each company).

 

Following good levels of early applications, an allotment of 13,603,037 new Ordinary Shares, in respect of the 2021/22 tax year, was made on 4 February 2022. It is intended that a further allotment for the 2021/22 tax year will be made on 22 March 2022, with a final allotment for the tax year on or before 5 April 2022. An allotment for the 2022/23 tax year will take place after 5 April 2022, and on or before 3 June 2022, once the Offer has closed. Further details regarding the new Ordinary Shares issued under the Offer for Subscription can be found in Note 12 to the Financial Statements.

 

This additional liquidity will enable your Company to continue to expand the portfolio by investing in ambitious, growth focused private and AIM quoted companies that operate across a broad range of market sectors, and which are capable of generating capital gains. It will also ensure that existing portfolio companies that are making tangible commercial progress can continue to be supported through follow-on funding. Furthermore, the funds raised will allow your Company to maintain its share buy-back policy, whilst also spreading costs over a wider asset base in line with the objective of maintaining a competitive total expense ratio for the benefit of all Shareholders.

 

Share Buy-backs

 

Shareholders will be aware that a primary objective for the Board is to ensure that the Company retains sufficient liquidity for making investments in line with its stated policy, and for the continued payment of dividends. However, the Directors also acknowledge the need to maintain an orderly market in the Company's shares and have, therefore, delegated authority to the Manager to buy back shares in the market for cancellation or to be held in treasury, subject always to such transactions being in the best interests of Shareholders.

 

It is intended that the Company should seek to maintain a discount that is approximately 5% below the latest published NAV per share, subject to market conditions, availability liquidity and the maintenance of the Company's VCT qualifying status.

 

VCT Regulatory Developments

 

During the period under review there have been no further amendments to the rules governing VCTs. The Autumn Budget was delivered on 27 October 2021 and did not propose any changes to the legislation governing VCTs.

 

The Directors and the Manager continue to apply the International Private Equity and Venture Capital Valuation (IPEV) Guidelines as the central methodology for all private company valuations. The IPEV Guidelines are the prevailing framework for fair value information in the private equity and venture capital industry.

 

Environmental, Social and Governance (ESG)

 

The Board is cognisant of the importance of ESG principles and believes that each portfolio company should behave responsibly towards the environment and society, whilst operating in line with governance best practice. The Directors are pleased to report that the Manager has increased its focus on ESG and has integrated the core criteria into its investment appraisal process. Additionally, a robust framework has been developed to ensure that any ESG considerations are monitored and managed carefully throughout the period of investment.

 

In May 2021, the Manager became a signatory to the internationally recognised Principles for Responsible Investment, demonstrating its commitment to include ESG as an integral part of its investment decision making and ownership. The Manager has also become a signatory to the Investing in Women Code, which aims to improve female entrepreneurs' access to tools, resources and finance, supporting diversity and inclusion in access to finance.

 

Although neither the Company nor the Manager are currently required to disclose climate related financial information in line with the Task Force on Climate related Financial Disclosures (TCFD), they recognise the aim and importance of the TCFD recommendations to provide a foundation to improve investors' ability to appropriately assess climate-related risk and opportunities. Disclosing information against the TCFD recommendations remains an objective of the Manager as part of its ESG initiatives and progress will be monitored by the Directors.

 

Maven Capital Partners LLP (Maven)

 

As noted in the 2021 Interim Report, Mattioli Woods plc completed the acquisition of Maven on 1 July 2021. The Directors are pleased to confirm that, following this strategic development, there has been no material change to the management of your Company. As previously outlined, Maven now operates as an independently managed subsidiary of Mattioli Woods, retaining its regional business model, people and brand in entirety, with no direct impact for Maven's VCT clients, Shareholders or investee companies. Your Board considers this to be a positive step in the evolution of Maven and does not anticipate any significant operational changes, with Bill Nixon remaining as Managing Partner and lead VCT fund manager. In addition, the investment team and support staff providing company secretarial, accounting and administrative services, are all continuing to operate as before.

 

Mattioli Woods is one of the UK's leading providers of wealth management and financial planning services and Maven offers a highly complementary fit with its existing operations. Maven and Mattioli Woods share a common objective of continuing to expand the enlarged business under PLC ownership. Both businesses are well known to each other and there is strong cultural alignment, as well as a common focus on providing clients with the best possible service. Further details on Mattioli Woods can be found at www.mattioliwoods.com.

 

Annual General Meeting (AGM)

 

The Directors are pleased to confirm that, subject to no variation in the guidelines in relation to the pandemic, the 2022 AGM will be held in the London office of Maven Capital Partners UK LLP on 6 April 2022, commencing at 12:30pm. The Notice of Annual General Meeting can be found in the Annual Report.

 

Ukraine

 

As at the date of publication of this Annual Report, global attention has become focused on the evolving situation in Ukraine and the significant humanitarian issues that are unfolding. Whilst the economic impact of these developments are not yet fully known, it is likely that financial markets and commodity prices will experience some volatility over the coming period. The Board and the Manager will continue to monitor the situation closely and remain hopeful that a swift and peaceful resolution can be achieved.

 

The Future

 

Your Company has made further significant progress in the financial year, delivering growth in line with its core investment objective. Your Board remains optimistic that the portfolio of investee companies has sufficient sector diversity and balance, reflecting its hybrid private and AIM quoted company investment strategy. The additional liquidity provided by the current fund raising will facilitate the continuation of this approach, and it is anticipated that there will be further expansion and development of the portfolio in the year ahead, which should support the continued growth in Shareholder value and help to maintain a programme of regular tax-free distributions.

 

 

Atul Devani

Chairman

 

7 March 2022

 

 

 

Business Report

 

This Business Report is intended to provide an overview of the strategy and business model of the Company, as well as the key measures used by the Directors in overseeing its management. The Company is a VCT and invests in accordance with the investment objective set out below.

 

Investment Objective

 

The Company aims to achieve long-term capital appreciation and generate income for Shareholders.

 

Business Model and Investment Policy

 

The Company intends to achieve its objective by:

 

• investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/AQSE quoted companies that meet the criteria for VCT qualifying investments and have strong growth potential;

 

• investing no more than £1.25 million in any company in one year and no more than 15% of the Company's assets by cost in one business at any time; and

 

• borrowing up to 15% of net asset value, if required and only on a selective basis, in pursuit of its investment strategy.

 

Principal and Emerging Risks and Uncertainties

 

The Board and the Audit & Risk Committee have an ongoing process for identifying, evaluating and monitoring the principal and emerging risks and uncertainties facing the Company. The risk register and dashboard form key parts of the Company's risk management framework used to carry out a robust assessment of the risks, including a significant focus on the controls in place to mitigate them. The principal and emerging risks and uncertainties facing the Company are considered to be as follows:

 

Investment Risk

 

The majority of the Company's investments are in small and medium sized unquoted UK companies and AIM/AQSE quoted companies which, by their nature, carry a higher level of risk and lower liquidity than investments in large quoted companies. The Board aims to limit the risk attached to the investment portfolio as a whole by ensuring that a robust and structured selection, monitoring and realisation process is applied. The Board reviews the investment portfolio with the Manager on a regular basis.

 

The Company manages and minimises investment risk by:

 

• diversifying across a large number of companies;

 

• diversifying across a range of economic sectors;

 

• actively and closely monitoring the progress of investee companies;

 

• co-investing with other clients of Maven, other VCT managers and/or other co-investment partners;

 

• ensuring valuations of underlying investments are made fairly and reasonably (see Notes to the Financial Statements 1(e), 1(f) and 16 in the Annual Report for further details);

 

• taking steps to ensure that share price discount is managed appropriately; and

 

• choosing and appointing an FCA authorised investment manager with the skills, experience and resources required to achieve the investment objective, with ongoing monitoring to ensure the Manager is performing in line with expectations.

 

Operational Risk

 

The Board has been aware of the heightened cyber security risk and potential consequences of IT failure during the pandemic, particularly in relation to the reliance on remote working practices by the Manager and key third parties during this period. The Board has closely monitored the systems and controls in place to prevent or mitigate against a systems or data security failure and the overall effectiveness of business continuity arrangements of the Manager and third parties.

 

VCT Qualifying Status Risk

 

The Company operates in a complex regulatory environment and faces a number of related risks, including:

 

• becoming subject to capital gains tax on the sale of its investments as a result of a breach of Section 274 of the Income Tax Act 2007;

 

• loss of VCT status and the consequential loss of tax reliefs available to Shareholders as a result of a breach of the VCT Regulations;

 

• loss of VCT status and reputational damage as a result of serious breach of other regulations such as the FCA Listing Rules and the Companies Act 2006 (the Companies Act); and

 

• increased investment restrictions resulting from the EU State Aid Rules incorporated by the Finance (No. 2) Act 2015 and the Finance Act 2018.

 

The Board works closely with the Manager to ensure compliance with all applicable and upcoming legislation, such that VCT qualifying status is maintained. Further information on the management of this risk is detailed under other headings in this Business Report.

 

Legislative and Regulatory Risk

 

The Directors strive to maintain a good understanding of the changing regulatory agenda and consider emerging issues so that appropriate changes can be implemented and developed in good time. In order to maintain its approval as a VCT, the Company is required to comply with current VCT legislation in the UK as well as the EU State Aid Rules. Changes to either legislation could have an adverse impact on Shareholder investment returns, whilst maintaining the Company's VCT status. The Board and the Manager continue to make representations where appropriate, either directly or through relevant industry bodies such as the Association of Investment Companies (AIC), the British Venture Capital Association (BVCA) and the Venture Capital Trust Association (VCTA).

 

The Company has retained Philip Hare & Associates LLP as its principal VCT adviser and also uses the services of a number of other VCT advisers on a transactional basis.

 

Breaches of other regulations including, but not limited to, the Companies Act, the FCA Listing Rules, the FCA Disclosure Guidance and Transparency Rules, the General Data Protection Regulation (GDPR), and the Alternative Investment Fund Managers Directive (AIFMD), could lead to a number of detrimental outcomes and reputational damage. Breaches of controls by service providers to the Company could also lead to reputational loss or damage.

 

The AIFMD, which regulates the management of alternative investment funds, including VCTs, introduced an authorisation and supervisory regime for all investment companies in the EU. The Company is a small registered, internally managed alternative investment fund under the AIFMD, and its status as such is unchanged as a result of the UK's departure from the EU. The Company is also required to comply with tax legislation under the Foreign Account Tax Compliance Act and the Common Reporting Standard. The Company has appointed City Partnership to act on its behalf to report annually to HM Revenue & Customs (HMRC) and ensure compliance with this legislation.

 

Climate Change and Social Responsibility Risk

 

The Board recognises that climate change is an important emerging risk that all companies should take into consideration within their strategic planning. As referred to elsewhere in this Strategic Report and in the Statement of Corporate Governance, the Company has little direct impact on environmental issues. However, the Company has introduced measures to reduce the cost and environmental impact of the production and circulation of Shareholder documentation such as the annual and interim reports. This has resulted in a significant reduction in the number of paper copies being printed and posted, with fewer than 12% of Shareholders now receiving printed reports.

 

The Board is aware that the Manager is increasing efforts in relation to the identification of environmental risks and opportunities, and is developing its ESG policy accordingly. Environmental risk is a fundamental aspect of due diligence and industry specialists are assigned where there may be specific concerns in relation to a potential business or sector. The results are then factored into the decision making process for new investments. VCTs in general are regarded as supporting small and medium sized enterprises, which helps to create local employment opportunities across a range of UK geographical regions.

 

Ukraine

 

Another emerging risk is the ongoing situation in Ukraine, which the Board is monitoring closely. Whilst the impact on the Company is unknown, it is acknowledged that there is an increased cyber security risk. The Manager is taking steps to mitigate this risk, including oversight of third parties. 

 

Other Key Risks

 

Governance Risk

 

The Directors are aware that an ineffective Board could have a negative impact on the Company and its Shareholders. The Board recognises the importance of effective leadership and board composition, and this is ensured by completing an annual evaluation process, with action being taken if required.

 

Management Risk

 

The Directors are aware of the risk that investment opportunities could fail, or the management of the VCT could breach the Management and Administration Deed or regulatory parameters, due to lack of knowledge and/or experience of the investment professionals acting on behalf of the Company. To manage this risk, the Board has appointed Maven as investment manager, as it employs skilled professionals with the required VCT knowledge and experience. In addition, the Board takes comfort that the Manager's controls have been updated to ensure compliance with the Senior Managers and Certification Regime (SMCR).

 

The Directors are also mindful of the impact that the loss of the Manager's key employees could have on both investment opportunities that may be lost or existing investments that may fail. The Board is reassured by the Manager's approach to incentivising staff and ensuring that adequate notice periods are included in all contracts of employment.

 

Financial and Liquidity Risk

 

As most of the investments require a mid to long term commitment and are relatively illiquid, the Company retains a portion of the portfolio in cash and listed investment trusts in order to finance any new or follow-on investment opportunities. The Company has only limited direct exposure to currency risk and does not enter into any derivative transactions.

 

Political Risk

 

Although the EU (Future Relationship) Act 2020 came into effect on 1 January 2021, the full political, economic and legal consequences of the UK leaving the EU are not yet fully known. It is possible that investments in the UK may be more difficult to value and assess for suitability of risk, harder to buy or sell, and may be subject to greater or more frequent rises and falls in value. In the longer term, there is likely to be a period of uncertainty as the UK seeks to negotiate its ongoing relationship with the EU and other global trade partners.

 

In the future, UK laws and regulations, including those relating to investment companies and AIFMs, may diverge from those of the EU. This may lead to changes in the operation of the Company, the rights of investors, or the list of territories in which the shares of the Company can be promoted or sold.

 

The Board regularly reviews the political situation, together with any associated changes to the economic, regulatory and legislative environment, in order to ensure that any risks are mitigated as effectively as possible.

 

Economic Risk

 

The valuation of investment companies may be affected by underlying economic conditions such as fluctuating interest rates and the availability of bank finance, which can be impacted during times of geopolitical uncertainty and fluctuating markets, including during the coronavirus pandemic. Investee companies may also be directly impacted by the economic effects of the pandemic, such as insufficient funds to carry the business through the crisis, market conditions affecting their valuations or the risk of lockdown restrictions limiting the ability to conduct new business or recruitment. The Manager has provided enhanced support and oversight to investee companies where needed and in some cases can consider follow-on funding. The diverse portfolio of the Company has limited the overall impact of the economic effects of the pandemic. The economic and market environment is kept under constant review and the investment strategy of the Company is adapted so far as possible to mitigate emerging risks.

 

Credit Risk

 

The Company may hold financial instruments and cash deposits and is dependent on counterparties discharging their agreed responsibilities. The Directors consider the creditworthiness of the counterparties to such instruments and seek to ensure that there is no undue concentration of exposure to any one party.

 

An explanation of certain economic and financial risks and how they are managed is contained in Note 16 to the Financial Statements in the Annual Report.

 

Statement of Compliance with Investment Policy

 

The Company is adhering to its stated investment policy and managing the risks arising from it. This can be seen in various tables and charts throughout the Annual Report, from information provided in the Chairman's Statement and in the Investment Manager's Review. A review of the Company's business, its position as at 30 November 2021 and its performance during the year then ended is included in the Chairman's Statement, which also includes an overview of the Company's business model and strategy.

 

The management of the investment portfolio has been delegated to Maven, which also provides company secretarial, administrative and financial management services to the Company. The Board is satisfied with the depth and breadth of the Manager's resources and its nationwide network of offices, which supply new deals and enable it to monitor the geographically widespread portfolio of companies effectively.

 

The Investment Portfolio Summary in the Annual Report discloses the investments in the portfolio and the degree of co-investment with other clients of the Manager. The portfolio analysis charts in the Annual Report show the profile of the portfolio by industry sector and by value. They also show the hybrid structure of the portfolio and the balance between growth capital investments, more mature investments and AIM/AQSE quoted investments. The level of qualifying investments is monitored continually by the Manager and reported to the Audit & Risk Committee quarterly, or as otherwise required.

 

Key Performance Indicators (KPIs)

 

During the year, the net return on ordinary activities before taxation was £6,731,000 (2020: £273,000), gains on investment were £8,550,000 (2020: £782,000) and earnings per share were 8.49p (2020: 0.35p). The Directors also use a number of Alternative Performance Measures (APMs) in order to assess the Company's success in achieving its objectives, and these also enable Shareholders and prospective investors to gain an understanding of its business. The APMs are shown in the Financial Highlights in the Annual Report.

 

In addition, the Board considers the following to be KPIs:

 

• NAV total return;

 

• annual yield;

 

• share price discount to NAV;

 

• investment income; and

 

• operational expenses.

 

The NAV total return is considered to be a more appropriate long-term measure of Shareholder value as it includes both the current NAV per share and the sum of dividends paid to date. The annual yield is the total dividends paid for the financial year, expressed as a percentage of the NAV per Ordinary Share at the preceding year end. The Directors seek to pay dividends to provide a yield and comply with the VCT rules, taking account of the level of distributable reserves, profitable realisations in each accounting period and the Company's future cash flow projections. The share price discount to NAV is the percentage by which the mid-market price of a share is lower than the most recently published NAV per share. A historical record of these measures is shown in the Financial Highlights in the Annual Report. The change in the profile of the portfolio is reflected in the Summary of Investment Changes in the Annual Report. Definitions of these APMs can be found in the Glossary in the Annual Report. The Board also reviews the Company's investment income and operational expenses on a quarterly basis, as the Directors consider that both of these elements are important components in the generation of Shareholder returns. Further information can be found in Notes 2 and 4 to the Financial Statements in the Annual Report.

 

There is no VCT index against which to compare the performance of the Company. However, for reporting to the Board and Shareholders, the Manager uses comparisons with the most appropriate index, being the FTSE AIM All-Share Index. The Directors also consider non-financial performance measures such as the flow of investment proposals.

 

In addition, the Directors consider economic, regulatory and political trends and factors that may impact on the Company's future development and performance.

 

Valuation Process

 

Investments held by Maven Income and Growth VCT 3 PLC in unquoted companies are valued in accordance with the International Private Equity and Venture Capital Valuation (IPEV) Guidelines. Investments quoted or traded on a recognised stock exchange, including AIM, are valued at their bid prices.

 

Share Buy-backs

 

At the forthcoming AGM, the Board will seek the necessary Shareholder authority to continue to conduct share buy-backs under appropriate circumstances.

 

The Board's Duty and Stakeholder Engagement

 

The Directors recognise the importance of an effective Board and its ability to discuss, review and make decisions to promote the long-term success of the Company and protect the interests of its key stakeholders. As required by provision 5 of the AIC Code (and in line with the UK Code), the Board has discussed the Directors' duty under Section 172 of the Companies Act and how the interests of key stakeholders have been considered in the Board discussions and decision making during the year.

 

This has been summarised in the table below:

 

Form of engagement

Influence on Board decision making

SHAREHOLDERS

AGM - Shareholders are encouraged to attend the AGM and are provided with the opportunity to ask questions and engage with the Directors and the Manager. Shareholders are also encouraged to exercise their right to vote on the resolutions proposed at the AGM.

 

Shareholder documents - the Company reports formally to Shareholders by publishing Annual and Interim Reports, normally in March and July each year. In the instance of a corporate action taking place, the Board will communicate with Shareholders through the issue of a Circular and, if required, a Prospectus.

 

In addition, significant matters or reporting obligations are disseminated to Shareholders by way of Stock Exchange Announcements.

 

The Secretary acts as a point of contact for the Board and communications received from Shareholders are circulated to the whole Board.

 

 

Dividend declarations - the Board recognises the importance of tax-free dividends to Shareholders and takes this into consideration when making decisions to pay interim and propose final dividends for each year. Further details regarding dividends for the year under review can be found in the Chairman's Statement in the Annual Report.

 

Share buy-back policy - the Directors recognise the importance to Shareholders of the Company maintaining an active buy-back policy and considered this when establishing the current programme. Further details can be found in the Chairman's Statement and in the Directors' Report in the Annual Report.

 

Offer for Subscription - in making a decision to launch an Offer for Subscription, the Directors considered that it would be in the interest of Shareholders to continue to grow the portfolio and make investments across a diverse range of sectors. By growing the Company, costs are spread over a wider asset base, which helps to promote a competitive total expense ratio, which is in the interests of Shareholders. In addition, the increased liquidity helps support the buy-back policy referred to above. Further details regarding the current Offer for Subscription can be found in the Chairman's Statement in the Annual Report.

 

Liquidity management - in order to generate income and add value for Shareholders, the Board has an active liquidity management policy, which has the objective of generating income from the cash held prior to investment. Further details regarding the liquidity management policy can be found in the Investment Manager's Review in the Annual Report.

 

ENVIRONMENT AND SOCIETY

The Directors and the Manager take account of the social environment and ethical factors impacted by the Company and the investments that it makes.

 

The Directors and the Manager are aware of their duty to act in the interests of the Company and acknowledge that there are risks associated with investment in companies that fail to conduct business in a socially responsible manner. Further details can be found in the Statement of Corporate Governance in the Annual Report.

 

PORTFOLIO COMPANIES

Quarterly Board Meetings - the Manager reports to the Board on the portfolio companies and the Directors challenge the Manager where they feel it is appropriate. The Manager then communicates directly with each portfolio company, normally through the Maven representative who sits on the board of the portfolio company.

 

The Directors are aware that the exercise of voting rights is key to promoting good corporate governance and, through the Manager, ensures that the portfolio companies are encouraged to adopt best practice corporate governance. The Board has delegated the responsibility for monitoring the portfolio companies to the Manager and has given it discretion to vote in respect of the Company's holdings in the investment portfolio, in a way that reflects the concerns and key governance matters discussed by the Board. From time to time, the management teams of investee companies give presentations to the Board. The Manager's ESG assessment of investee companies focuses heavily on their impact on their environment, challenging fundamental aspects such as energy and emissions usage, and targets an approach to waste and recycling as well as broader social themes such as the companies' approach to diversity and inclusion in the workplace and their work with charities.

 

The Board is also mindful that, as the portfolio expands and the proportion of early stage investment increases, follow-on funding will represent an important part of the Company's investment strategy and this forms a key part of the Directors' discussions on valuations, risk management and fundraising.

 

MANAGER

Quarterly Board Meetings - the Manager attends every Board Meeting and presents a detailed portfolio analysis and reports on key issues such as VCT compliance, investment pipeline and utilisation of any new monies raised.

 

The Manager is responsible for implementing the investment objective and the strategy agreed by the Board. In making a decision to launch any Offer for Subscription, the Board needs to consider that the Company requires to have sufficient liquidity to continue to expand and broaden the investment portfolio in line with the strategy, including the provision of follow-on funding, as referred to above.

 

REGISTRAR

Annual review meetings and control reports.

 

The Directors review the performance of all third party service providers on an annual basis, including ensuring compliance with GDPR. During the year, the decision was made to change registrar and City Partnership was appointed on 25 October 2021.

 

CUSTODIAN

Regular statements and control reports received, with all holdings and balances reconciled.

 

The Directors review the performance of all third party providers on an annual basis, including oversight of securing the Company's assets.

 

 

Employee, Environmental and Human Rights Policy

 

The Company has no direct employee or environmental responsibilities, nor is it responsible directly for the emission of greenhouse gases. The Board's principal responsibility to Shareholders is to ensure that the investment portfolio is managed and invested properly. As the Company has no employees, it has no requirement to report separately on employment matters. The Board comprises four male Directors and delegates responsibility for diversity to the Nomination Committee, as explained in the Statement of Corporate Governance in the Annual Report.

 

The management of the portfolio is undertaken by the Manager through members of its portfolio management team. The Manager engages with the Company's underlying investee companies in relation to their corporate governance practices and in developing their policies on social, community and environmental matters and further information can be found in the Statement of Corporate Governance. Additional work is being carried out by the Manager to establish a framework for the effective capture of ESG information, consistently across all investee companies. Maven will be overseeing the collation of this information for the benefit of the Board, but will also be supporting individual investee companies to identify their ESG risks and opportunities and, where potential improvements are identified, will work jointly with the business to make positive changes. In light of the nature of the Company's business, there are no relevant human rights issues and, therefore, the Company does not have a human rights policy.

 

Auditor

 

The Company's Auditor is required to report if there are any material inconsistencies between the content of the Strategic Report and the Financial Statements. The Independent Auditor's Report can be found in the Annual Report.

 

Future Strategy

 

The Board and Manager intend to maintain the policies set out above for the year ending 30 November 2022, as it is believed that these are in the best interests of Shareholders.

 

Approval

 

The Business Report, and the Strategic Report as a whole, was approved by the Board of Directors and signed on its behalf by:

 

 

 

Atul Devani

Director

 

7 March 2022

 

 

 

 

 

Income Statement

 

For the year ended 30 November 2021

 

 

 

Year ended

30 November 2021

Year ended

30 November 2020

 

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on investment

 

-

8,550

8,550

-

782

782

Income from investments

 

755

-

755

928

-

928

Other income

 

2

-

2

21

-

21

Investment management fees

 

(444)

(1,776)

(2,220)

(226)

(905)

(1,131)

Other expenses

 

(356)

-

(356)

(327)

-

(327)

Net return on ordinary activities before

 

(43)

6,774

6,731

396

(123)

273

taxation

 

 

 

 

 

 

 

 

Tax on ordinary activities

 

-

-

-

(63)

63

-

Return attributable to Equity Shareholders

 

(43)

6,774

6,731

333

(60)

273

 

Earnings per share (pence)

 

(0.05)

 

8.54

 

8.49

 

0.43

 

(0.08)

 

0.35

 

All gains and losses are recognised in the Income Statement.

 

All items in the above statement are derived from continuing operations. The Company has only one class of business and one reportable segment, the results of which are set out in the Income Statement and Balance Sheet. The Company derives its income from investments made in shares, securities and bank deposits.

 

There are no potentially dilutive capital instruments in issue and, therefore, no diluted earnings per share figures are relevant. The basic and diluted earnings per share are, therefore, identical.

 

The Notes are an integral part of the Financial Statements and can be found in full in the Annual Report.

 

 

 

 

 

Statement of Changes in Equity

 

For the year ended 30 November 2021

 

Year ended 30 November 2021

Non-distributable Reserves

Distributable Reserves

 

Share capital

£'000

Share premium account

£'000

Capital redemption reserve

£'000

Capital reserve unrealised

£'000

Capital reserve realised

£'000

Special distributable reserve

£'000

Revenue reserve

£'000

Total

£'000

 

At 30 November 2020

7,965

6,285

153

(722)

18

30,332

788

44,819

 

Net return

-

-

-

10,391

(1,841)

(1,776)

(43)

6,731

 

Dividends paid

-

-

-

-

-

(1,783)

-

(1,783)

 

Repurchase and cancellation of shares

(134)

-

134

-

-

(753)

-

(753)

Net proceeds of DIS issue

35

151

-

-

-

-

-

186

 

At 30 November 2021

7,866

6,436

287

9,669

(1,823)

26,020

745

49,200

 

 

 

Year ended 30 November 2020

Non-distributable Reserves

Distributable Reserves

Share Capital

£'000

Share premium account

£'000

Capital redemption reserve

£'000

Capital reserve unrealised

£'000

Capital reserve realised

£'000

Special distributable reserve

£'000

Revenue reserve

£'000

Total

£'000

At 30 November 2019

6,798

-

35

(1,486)

-

34,144

1,247

40,738

Net return

-

-

-

764

18

(842)

333

273

Share premium

cancellation costs

-

(11)

-

-

-

-

-

(11)

Dividends paid

-

-

-

-

-

(2,377)

(792)

(3,169)

Repurchase and

cancellation of shares

(118)

-

118

-

-

(593)

-

(593)

Net proceeds of share issue

1,251

6,155

-

-

-

-

-

7,406

Net proceeds of DIS issue

34

141

-

-

-

-

-

175

At 30 November 2020

7,965

6,285

153

(722)

18

30,332

788

44,819

 

The capital reserve unrealised is generally non-distributable other than the part of the reserve relating to gains/(losses) attributable to readily realisable quoted investments which are distributable.

 

The Notes are an integral part of the Financial Statements and can be found in full in the Annual Report.

 

Balance Sheet

 

As at 30 November 2021

 

30 November 2021

30 November 2020

£'000

£'000

Fixed assets

 

 

Investments at fair value through profit or loss

43,410

34,229

 

Current assets

 

 

Debtors

508

320

Cash

5,648

10,478

 

6,156

10,798

Creditors

 

 

Amounts falling due within one year

(366)

(208)

Net current assets

5,790

10,590

Net assets

49,200

44,819

Capital and reserves

 

 

Called up share capital

7,866

7,965

Share premium account

6,436

6,285

Capital redemption reserve

287

153

Capital reserve - unrealised

9,669

(722)

Capital reserve - realised

(1,823)

18

Special distributable reserve

26,020

30,332

Revenue reserve

745

788

Net assets attributable to Ordinary Shareholders

49,200

44,819

 

 

 

Net asset value per Ordinary Share (pence)

62.55

56.27

 

The Financial Statements of Maven Income and Growth VCT 3 PLC, registered number 04283350, were approved by the Board of Directors and were signed on its behalf by:

 

 

 

Atul Devani

Director

 

7 March 2022

 

The Notes are an integral part of the Financial Statements and can be found in full in the Annual Report.

 

 

Cash Flow Statement

 

For the Year Ended 30 November 2021

 

 

Year ended

30 November 2021

£'000

Year ended

30 November 2020

£'000

Net cash flows from operating activities

(1,574)

(457)

 

 

 

Cash flows from investing activities

 

 

Purchase of investments

(3,334)

(10,351)

Sale of investments

2,428

3,656

Net cash flows from investing activities

(906)

(6,695)

Cash flows from financing activities

 

 

Equity dividends paid

(1,783)

(3,169)

Issue of Ordinary Shares

186

7,581

Share premium cancellation costs

-

(11)

Repurchase of Ordinary Shares

(753)

(593)

Net cash flows from financing activities

(2,350)

3,808

 

 

 

Net decrease in cash

(4,830)

(3,344)

 

 

 

Cash at beginning of year

10,478

13,822

Cash at end of year

5,648

10,478

 

 

The Notes are an integral part of the Financial Statements and can be found in full in the Annual Report.

 

Notes to the Financial Statements

 

For the Year Ended 30 November 2021

 

1. Accounting Policies

 

The Company is a public limited company, incorporated in England & Wales and its registered office is shown in the Corporate Summary.

 

(a) Basis of preparation

 

The Financial Statements have been prepared on a going concern basis, including an assessment of the impact of COVID-19 on the finances of the Company, as covered in the Directors' Report in the Annual Report. The Financial Statements have been prepared under the historical cost convention, as modified by the revaluation of investments and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland, and in accordance with the Statement of Recommended Practice for Investment Trust Companies and Venture Capital Trusts (the SORP) issued by the AIC in April 2021.

 

(b) Income

 

Dividends receivable on equity shares and unit trusts are treated as revenue for the period on an ex-dividend basis. Where no ex-dividend date is available dividends receivable on or before the year end are treated as revenue for the period. Provision is made for any dividends not expected to be received. The fixed returns on debt securities and non-equity shares are recognised on a time apportionment basis so as to reflect the effective interest rate on the debt securities and shares. Provision is made for any income not expected to be received. Interest receivable from cash and short term deposits and interest payable are accrued to the end of the year.

 

(c) Expenses

 

All expenses are accounted for on an accruals basis and charged to the Income Statement. Expenses are charged through the revenue account, except as follows:

 

• expenses that are incidental to the acquisition and disposal of an investment are charged to capital; and

 

• expenses are charged to the special distributable reserve where a connection with the maintenance or enhancement of the value of the investments can be demonstrated. In this respect, the investment management fee and performance fee have been allocated 20% to revenue and 80% to the special distributable reserve to reflect the Company's investment policy and prospective income and capital growth.

 

(d) Taxation

 

Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events that result in an obligation to pay more tax in the future or right to pay less tax in the future have occurred at the balance sheet date. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the underlying timing differences can be deducted. Timing differences are differences arising between the Company's taxable profits and its results as stated in the Financial Statements that are capable of reversal in one or more subsequent periods.

 

Deferred tax is measured on a non-discounted basis at the tax rates that are expected to apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

 

The tax effect of different items of income/gain and expenditure/loss is allocated between capital reserves and revenue account on the same basis as the particular item to which it relates, using the Company's effective rate of tax for the period.

 

UK Corporation tax is provided at amounts expected to be paid/recovered using the tax rates and laws that have been enacted or substantively enacted at the balance sheet date.

 

(e) Investments

 

In valuing unlisted investments, the Directors follow the criteria set out below. These procedures comply with the revised IPEV Guidelines for the valuation of private equity and venture capital investments. Investments are recognised at their trade date and are designated by the Directors as fair value through profit and loss. At subsequent reporting dates, investments are valued at fair value, which represents the Directors' view of the amount for which an asset could be exchanged between knowledgeable and willing parties in an arm's length transaction. This does not assume that the underlying business is saleable at the reporting date or that its current shareholders have an intention to sell their holding in the near future.

 

A financial asset or liability is generally derecognised when the contract that gives rise to it is settled, sold, cancelled or expires.

 

1. For early stage investments completed in the reporting period, fair value is determined using the price of recent investment, calibrating for any material change in the trading circumstances of the investee company. Other early stage investments are valued using a milestone approach, in particular where it is considered there are no deemed current or short-term future maintainable earnings or positive cashflows.

 

2. Whenever practical, recent investments will be valued by reference to a material arm's length transaction or a quoted price.

 

3. Mature companies are valued by applying a multiple to their maintainable earnings to determine the enterprise value of the company.

 

To obtain a valuation of the total ordinary share capital held by management and the institutional investors, the value of third party debt, institutional loan stock, debentures and preference share capital is deducted from the enterprise value. The effect of any performance related mechanisms is taken into account when determining the value of the ordinary share capital.

 

4. In the absence of evidence of a deterioration, or strong defensible evidence of an increase in value, the fair value is determined to be that reported at the previous balance sheet date.

 

5. All unlisted investments are valued individually by the portfolio management team of Maven. The resultant valuations are subject to detailed scrutiny and approval by the Directors of the Company.

 

6. In accordance with normal market practice, investments quoted on AIM or a recognised stock exchange are valued at their bid market price.

 

(f) Fair value measurement

 

Fair value is defined as the price that the Company would receive upon selling an investment in a timely transaction to an independent buyer in the principal or the most advantageous market of the investment. A three-tier hierarchy has been established to maximise the use of observable market data and minimise the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk, for example, the risk inherent in a particular valuation technique used to measure fair value, including such a pricing model and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable.

 

Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the reporting entity.

 

Unobservable inputs are inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on best information available in the circumstances.

 

The three-tier hierarchy of inputs is summarised in the three broad levels listed below:

 

• Level 1 - the unadjusted quoted price in an active market for identical assets or liabilities that the entity can access at the measurement date;

 

• Level 2 - inputs other than quoted prices included within Level 1 that are observable (i.e. developed using market data) for the asset or liability, either directly or indirectly; and

 

• Level 3 - inputs are unobservable (i.e. for which market data is unavailable) for the asset or liability.

 

(g) Gains and losses on investments

 

When the Company sells or revalues its investments during the year, any gains or losses arising are credited/charged to the Income Statement.

 

(h) Critical accounting judgements and key sources of estimation uncertainty

 

Disclosure is required of judgements and estimates made by the Board and the Manager in applying the accounting policies that have a significant effect on the Financial Statements. The area involving the highest degree of judgement and estimates is the valuation of early stage unlisted investments recognised in Note 8 to the Financial Statements in the Annual Report and explained in Note 1(e) above.

 

In the opinion of the Board and the Manager, there are no critical accounting judgements.

 

Reserves

 

Share premium account

 

The share premium account represents the premium above nominal value received by the Company on issuing shares net of issue costs. This reserve is non-distributable.

 

Capital redemption reserve

 

The nominal value of shares repurchased and cancelled is represented in the capital redemption reserve. This reserve is non-distributable.

 

Capital reserve - unrealised

 

Increases and decreases in the fair value of investments are recognised in the Income Statement and are then transferred to the capital reserve unrealised account. This reserve is non-distributable.

 

Capital reserve - realised

 

Gains or losses on investments realised in the year that have been recognised in the Income Statement are transferred to the capital reserve realised account on disposal. Furthermore, any prior unrealised gains or losses on such investments are transferred from the capital reserve unrealised account to the capital reserve realised account on disposal. This reserve is distributable.

 

Special distributable reserve

 

The total cost to the Company of the repurchase and cancellation of shares is represented in the special distributable reserve account. The special distributable reserve also represents capital dividends, capital investment management fees and the tax effect of capital items. This reserve is distributable.

 

Revenue reserve

 

The revenue reserve represents accumulated profits retained by the Company that have not been distributed to Shareholders as a dividend. This reserve is distributable.

 

Return per Ordinary Share

 

 

Year ended

30 November 2021

Year ended

30 November 2020

The returns per share have been based on the following figures:

 

 

 

 

 

Weighted average of Ordinary Shares

79,296,960

77,118,360

Revenue return

(£43,000)

£333,000

Capital return

£6,774,000

(£60,000)

Total return

£6,731,000

£273,000

 

Net asset value per Ordinary Share

 

The net asset value per Ordinary Share as at 30 November 2021 has been calculated using the number of Ordinary Shares in issue at that date of 2021: 78,660,439 (2020: 79,653,579).

 

Directors' Responsibility Statement

 

Each Director believes that, to the best of their knowledge:

 

• the Financial Statements have been prepared in accordance with the applicable accounting standards and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company as at 30 November 2021 and for the year to that date;

 

• the Directors' Report includes a fair review of the development and performance of the Company, together with a description of the principal risks and uncertainties that it faces; and

 

• the Annual Report and Financial Statements, taken as a whole, is fair, balanced and understandable and provides the information necessary for Shareholders to assess the Company's position and performance, business model and strategy.

 

Other Information

 

The Annual General Meeting will be held on Wednesday 6 April 2022, commencing at 12.30pm, at the offices of Maven Capital Partners UK LLP, Fifth Floor, 1-2 Royal Exchange Buildings, London EC3V 3LF.

 

The Annual Report and Financial Statements for the year ended 30 November 2021 will be issued to Shareholders and filed with the Registrar of Companies in due course.

 

The financial information contained within this announcement does not constitute the Company's statutory Financial Statements as defined in the Companies Act 2006. The statutory Financial Statements for the year ended 30 November 2020 have been delivered to the Registrar of Companies and contained an audit report which was unqualified and did not constitute statements under S498(2) or S498(3) of the Companies Act 2006.

 

Copies of this announcement, and of the Annual Report and Financial Statements for the year ended 30 November 2021, will be available, in due course, to the public at the office of Maven Capital Partners UK LLP, 205 West George Street, Glasgow G2 2LW; at the registered office of the Company, 1-2 Royal Exchange Buildings, London EC3V 3LF and on the Company's website at www.mavencp.com/migvct3.

 

Neither the content of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

The Annual Report will shortly be submitted to the National Storage Mechanism and will be available for inspection at: www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

By Order of the Board

 

Maven Capital Partners UK LLP

Secretary

 

7 March 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR BKOBBFBKDFNK
Date   Source Headline
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.